# Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic Anemia

> **NCT07078721** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 11 (estimated)

## Conditions studied

- Aplastic Anemia Idiopathic

## Interventions

- **RADIATION:** Total Marrow Irradiation
- **DRUG:** Fludarabine (FLU)
- **DRUG:** Melphalan (Mel)

## Key facts

- **NCT ID:** NCT07078721
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-20
- **Primary completion:** 2028-01
- **Final completion:** 2028-06
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07078721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07078721, "Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic Anemia". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07078721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*